Literature DB >> 8647939

The kidney is a major site of alpha(2)-antiplasmin production.

P A Menoud1, N Sappino, M Boudal-Khoshbeen, J D Vassalli, A P Sappino.   

Abstract

The serpin alpha2-antiplasmin (alpha2-AP) is the major circulating inhibitor of plasmin; it plays a determining role in the regulation of intravascular fibrinolysis, In addition to blood plasma, plasmin formation occurs in various organs where it is thought to fulfill a spectrum of functions not restricted to clot lysis. Alpha2-AP is synthesized by hepatocytes, but other possible sites of production have not been investigated. To explore the potential extravascular contribution of alpha2-AP in the regulation of proteolysis, we have isolated the murine alpha2-AP cDNA and determined its mRNA distribution in adult tissues. In addition to liver, kidneys are major sites of alpha2-AP mRNA accumulation in the mouse. The transcript is present in epithelial cells lining the convoluted portion of proximal tubules, and its accumulation is under androgen control. Human kidneys also contain high levels of alpha2-AP mRNA. Moderate amounts Of alpha2-AP mRNA are detected in other murine tissues such as muscle, intestine, central nervous system, and placenta. Our observations indicate that alpha2-AP can be synthesized in a number of tissues, where it could function as a distal regulator of plasmin-mediated extracellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647939      PMCID: PMC507332          DOI: 10.1172/JCI118694

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator.

Authors:  D Belin; J D Vassalli; C Combépine; F Godeau; Y Nagamine; E Reich; H P Kocher; R M Duvoisin
Journal:  Eur J Biochem       Date:  1985-04-15

2.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

Review 3.  Regulation of gene expression by androgens in murine kidney.

Authors:  J F Catterall; K K Kontula; C S Watson; P J Seppänen; B Funkenstein; E Melanitou; N J Hickok; C W Bardin; O A Jänne
Journal:  Recent Prog Horm Res       Date:  1986

4.  Plasminogen activator in the rodent brain.

Authors:  H Soreq; R Miskin
Journal:  Brain Res       Date:  1981-07-20       Impact factor: 3.252

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.

Authors:  M Samama; M Castel; O Matsuo; M Hoylaerts; H R Lijnen
Journal:  Thromb Haemost       Date:  1982-02-26       Impact factor: 5.249

7.  Morphological classification of renal cancer.

Authors:  S Störkel; E van den Berg
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.

Authors:  T Sasaki; T Morita; S Iwanaga
Journal:  J Biochem       Date:  1986-06       Impact factor: 3.387

9.  Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.

Authors:  S Kimura; N Aoki
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

10.  Migrating keratinocytes express urokinase-type plasminogen activator.

Authors:  S Morioka; G S Lazarus; J L Baird; P J Jensen
Journal:  J Invest Dermatol       Date:  1987-04       Impact factor: 8.551

View more
  16 in total

1.  PAI-1, fibrosis, and the elusive provisional fibrin matrix.

Authors:  D J Loskutoff; J P Quigley
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 2.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

3.  Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.

Authors:  C Barazzone; D Belin; P F Piguet; J D Vassalli; A P Sappino
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  A novel mechanism for the acquisition of virulence by a human influenza A virus.

Authors:  H Goto; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

5.  Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.

Authors:  I-Chu Tseng; Feng-Pai Chou; Sheng-Feng Su; Michael Oberst; Nandakumar Madayiputhiya; Ming-Shyue Lee; Jehng-Kang Wang; David E Sloane; Michael Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-11       Impact factor: 4.249

6.  Exogenous t-PA administration increases hippocampal mature BDNF levels. plasmin- or NMDA-dependent mechanism?

Authors:  Marion Rodier; Anne Prigent-Tessier; Yannick Béjot; Agnès Jacquin; Claude Mossiat; Christine Marie; Philippe Garnier
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

7.  α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.

Authors:  Yosuke Kanno; En Shu; Hiroyuki Kanoh; Ayaka Matsuda; Mariko Seishima
Journal:  Arthritis Res Ther       Date:  2017-02-03       Impact factor: 5.156

8.  In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells.

Authors:  I Irminger-Finger; J V Soriano; G Vaudan; R Montesano; A P Sappino
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

9.  Altered behavior in mice with deletion of the alpha2-antiplasmin gene.

Authors:  Eri Kawashita; Yosuke Kanno; Kanako Ikeda; Hiromi Kuretake; Osamu Matsuo; Hiroyuki Matsuno
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

Review 10.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.